GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Gross-Profit-to-Asset %

Consun Pharmaceutical Group (HKSE:01681) Gross-Profit-to-Asset % : 41.20% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Consun Pharmaceutical Group's annualized Gross Profit for the quarter that ended in Dec. 2023 was HK$2,374 Mil. Consun Pharmaceutical Group's average Total Assets over the quarter that ended in Dec. 2023 was HK$5,762 Mil. Therefore, Consun Pharmaceutical Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 41.20%.


Consun Pharmaceutical Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Consun Pharmaceutical Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Gross-Profit-to-Asset % Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.82 35.57 37.31 36.44 36.59

Consun Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.62 33.16 43.36 33.38 41.20

Competitive Comparison of Consun Pharmaceutical Group's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Gross-Profit-to-Asset % falls into.



Consun Pharmaceutical Group Gross-Profit-to-Asset % Calculation

Consun Pharmaceutical Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=2101.891/( (5463.393+6024.528)/ 2 )
=2101.891/5743.9605
=36.59 %

Consun Pharmaceutical Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=2374.074/( (5498.844+6024.528)/ 2 )
=2374.074/5761.686
=41.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Consun Pharmaceutical Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (HKSE:01681) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Executives
An Yubao 2101 Beneficial owner
Li Qian 2101 Beneficial owner
Central Success Developments Limited 2101 Beneficial owner
Aali Resources Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2301 Trustee
Zhang Lihua 2202 Interest of your spouse
An Meng 2101 Beneficial owner
Double Grace International Limited 2101 Beneficial owner
Bos Trustee Limited As Trustee 2201 Interest of corporation controlled by you

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines